Ugur Uygunoglu Selected Research

4-nitrobenzenesulfonate

1/2021

An uncommon disease included commonly in the differential diagnosis of neurological diseases: Neuro-Behçet's syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ugur Uygunoglu Research Topics

Disease

5	Multiple Sclerosis 01/2023 - 01/2014
4	Behcet Syndrome (Behcet's Syndrome) 10/2022 - 07/2015
3	Neuromyelitis Optica (Devic's Disease) 11/2023 - 10/2015
3	Migraine Disorders (Migraine) 09/2023 - 01/2015
3	COVID-19 10/2022 - 01/2022
2	Seizures (Absence Seizure) 01/2022 - 07/2020
1	Ganglion Cysts (Ganglion) 09/2023
1	Migraine without Aura (Common Migraine) 09/2023
1	Epilepsy (Aura) 09/2023
1	Unverricht-Lundborg Syndrome (Disease, Unverricht) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Infections 01/2022
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2021
1	Familial Mediterranean Fever (Periodic Disease) 10/2020
1	Movement Disorders (Movement Disorder) 07/2020
1	Relapsing-Remitting Multiple Sclerosis 07/2020
1	Encephalitis (Encephalitis, Rasmussen) 07/2020
1	Demyelinating Diseases (Demyelinating Disease) 01/2019
1	Tuberculosis (Tuberculoses) 10/2016
1	Spastic Paraparesis 01/2016
1	Transverse Myelitis (Necrotizing Myelitis) 10/2015
1	Headache (Headaches) 01/2015
1	Cerebrotendinous Xanthomatosis 12/2014
1	Ataxia (Dyssynergia) 12/2014
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2013
1	Stroke (Strokes) 01/2013

Drug/Important Bio-Agent (IBA)

2	Retinaldehyde (Retinal)IBA 09/2023 - 07/2015
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2023 - 01/2018
1	eculizumab FDA Link 11/2023
1	VaccinesIBA 10/2022
1	Inactivated VaccinesIBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	Myelin-Oligodendrocyte GlycoproteinIBA 02/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2022
1	4-nitrobenzenesulfonateIBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 10/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2020
1	N-Methylaspartate (NMDA)IBA 07/2020
1	Oligoclonal BandsIBA 01/2019
1	Infliximab (Remicade)FDA Link 10/2016
1	4-Aminopyridine (4 Aminopyridine)FDA Link 01/2016
1	Immunoglobulin G (IgG)IBA 10/2015
1	Aligeron (AS 2)IBA 01/2015
1	Piracetam (Nootropil)IBA 12/2014
1	AntibodiesIBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014

Therapy/Procedure

1	Nerve Block (Nerve Blocks) 01/2023
1	Carotid Endarterectomy 01/2013
1	Therapeutics 01/2013